| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.86B | 51.30B | 51.41B | 52.57B | 49.12B | 40.11B |
| Gross Profit | 5.21B | 4.95B | 4.08B | 6.27B | 6.21B | 2.20B |
| EBITDA | 1.85B | 1.53B | 729.00M | 3.07B | 3.07B | -773.00M |
| Net Income | 846.00M | 703.00M | 1.54B | 916.00M | 2.52B | -277.00M |
Balance Sheet | ||||||
| Total Assets | 70.41B | 69.90B | 75.08B | 73.87B | 72.18B | 64.18B |
| Cash, Cash Equivalents and Short-Term Investments | 12.49B | 12.01B | 12.04B | 8.04B | 10.13B | 8.77B |
| Total Debt | 21.13B | 21.51B | 24.46B | 24.75B | 22.69B | 23.00B |
| Total Liabilities | 42.66B | 42.03B | 48.22B | 49.42B | 48.86B | 43.70B |
| Stockholders Equity | 27.75B | 27.86B | 26.86B | 24.45B | 23.31B | 20.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 96.00M | -2.91B | -6.13B | 1.82B | -143.00M |
| Operating Cash Flow | 0.00 | 1.21B | -203.00M | -1.51B | 4.50B | 2.35B |
| Investing Cash Flow | 0.00 | 1.71B | 4.20B | -2.72B | -2.75B | -2.04B |
| Financing Cash Flow | 0.00 | -3.19B | -502.00M | 2.02B | -399.00M | 2.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥49.81B | 7.14 | ― | 6.31% | -8.44% | 9.50% | |
70 Outperform | ¥104.34B | 10.61 | ― | 3.70% | -3.06% | 1.15% | |
66 Neutral | ¥27.38B | 21.77 | ― | 4.13% | -2.96% | ― | |
64 Neutral | ¥34.16B | -185.54 | ― | 5.02% | -13.64% | -45.74% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥79.23B | 53.99 | ― | 1.24% | -12.05% | -97.36% | |
59 Neutral | ¥6.45B | 11.26 | ― | ― | -5.93% | -36.01% |